论文部分内容阅读
目的:评价老年慢性支气管炎急性发作期应用润肺清金汤联合头孢哌酮治疗的临床效果。方法:以数字随机法将我院收治的68例老年慢性支气管炎急性发作期患者分为观察组和对照组,两组分别采用润肺清金汤联合头孢哌酮与单纯头孢哌酮进行为期2周的治疗。结果:观察组和对照组的治疗总有效率(分别94.12%和76.47%)差异有统计学意义(P<0.05)。另外,治疗前,两组的CD3、CD4、CD8、CD4/CD8差异不明显,P>0.05。治疗后,观察组的CD3、CD4、CD8、CD4/CD8得到明显改善,与对照组相比,差异有统计学意义(P<0.05)。结论:润肺清金汤联合头孢哌酮在提高老年慢性支气管炎急性发作期患者的临床疗效和T淋巴细胞功能等方面具有显著优势,值得推广。
Objective: To evaluate the clinical effect of “Runfei Qingjin Decoction” combined with cefoperazone in acute exacerbation of chronic bronchitis. Methods: 68 cases of acute exacerbation of chronic bronchitis admitted to our hospital were randomly divided into observation group and control group. The two groups were treated with Runfei Qingjin Decoction combined with cefoperazone and cefoperazone for 2 weeks Treatment. Results: The total effective rate (94.12% and 76.47% respectively) in observation group and control group was statistically significant (P <0.05). In addition, before treatment, the two groups of CD3, CD4, CD8, CD4 / CD8 difference was not significant, P> 0.05. After treatment, the levels of CD3, CD4, CD8 and CD4 / CD8 in the observation group were significantly improved, with statistical significance (P <0.05). Conclusion: Runfei Qingjin Decoction combined with Cefoperazone has significant advantages in improving clinical efficacy and T lymphocyte function in elderly patients with acute exacerbation of chronic bronchitis and is worth promoting.